| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cell and Tumor Biology |
1 Microbiology and Tumor Biology Centre, Karolinska Institutet, Stockholm, Sweden and 2 Department of Biochemistry, Biomedical Centre, Uppsala University, Uppsala, Sweden
Requests for reprints: Maria G. Masucci, MTC Karolinska Institutet, Box 280, S-171 77 Stockholm, Sweden. Phone: 46-8-52486755; Fax: 46-8-331399; E-mail: Maria.Masucci{at}mtc.ki.se.
The oligopeptidase tripeptidyl-peptidase II (TPP II) is up-regulated Burkitt's lymphoma (BL) cells that overexpress the c-myc proto-oncogene and is required for their growth and survival. Here we show that overexpression of TPP II induces accelerated growth and resistance to apoptosis in human embryonic kidney 293 cells. This correlates with the appearance of multiple chromosomal aberrations, numerical and structural centrosome abnormalities, and multipolar cell divisions. Similar mitotic aberrations were also observed in a panel of BL lines and were suppressed, in parallel with TPP II down-regulation, upon reversion of BL-like characteristics in EBV-immortalized B lymphocytes carrying a tetracycline-regulated c-myc. Functional TPP II knockdown by small interfering RNA expression in BL cells caused the appearance of giant polynucleated cells that failed to complete cell division. Collectively, these data point to a role of TPP II in the regulation of centrosome homeostasis and mitotic fidelity suggesting that this enzyme may be a critical player in the induction and/or maintenance of genetic instability in malignant cells.
Key Words: TPP II c-Myc Burkitt's lymphoma mitosis siRNA
This article has been cited by other articles:
![]() |
J. Huai, E. Firat, A. Nil, D. Million, S. Gaedicke, B. Kanzler, M. Freudenberg, P. van Endert, G. Kohler, H. L. Pahl, et al. Activation of cellular death programs associated with immunosenescence-like phenotype in TPPII knockout mice PNAS, April 1, 2008; 105(13): 5177 - 5182. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Blanco, G. Larrinaga, I. Perez, J. I. Lopez, J. Gil, E. Agirregoitia, and A. Varona Acid, basic, and neutral peptidases present different profiles in chromophobe renal cell carcinoma and in oncocytoma Am J Physiol Renal Physiol, April 1, 2008; 294(4): F850 - F858. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Hong, L. Lei, B. Kunert, R. Naredla, S. E. Applequist, A. Grandien, and R. Glas Tripeptidyl-peptidase II Controls DNA Damage Responses and In vivo {gamma}-Irradiation Resistance of Tumors Cancer Res., August 1, 2007; 67(15): 7165 - 7174. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Varona, L. Blanco, J. I. Lopez, J. Gil, E. Agirregoitia, J. Irazusta, and G. Larrinaga Altered levels of acid, basic, and neutral peptidase activity and expression in human clear cell renal cell carcinoma Am J Physiol Renal Physiol, February 1, 2007; 292(2): F780 - F788. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |